Overall, these studies support a role of XPC expression in variable risk and outcomes of bladder cancer, although the exact mechanisms of epigenetic regulation, and the specific mechanisms by which risk is altered in low XPC, remains less clear. The gene discussed is XPC; the disease is urinary bladder carcinoma.